138 related articles for article (PubMed ID: 12504058)
1. Is there a preferred strength for regularly spaced 125I seeds in inverse-planned prostate implants?
Sloboda RS; Pedersen JE; Halperin R
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):234-44. PubMed ID: 12504058
[TBL] [Abstract][Full Text] [Related]
2. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
3. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
4. Comparison of seed loading approaches in prostate brachytherapy.
Butler WM; Merrick GS; Lief JH; Dorsey AT
Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143
[TBL] [Abstract][Full Text] [Related]
5. Effect of planning margin on dosimetric quality in 131Cs permanent prostate brachytherapy.
Li T; Fountain BL; Duffy EW
Brachytherapy; 2010; 9(2):159-64. PubMed ID: 19853535
[TBL] [Abstract][Full Text] [Related]
6. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
[TBL] [Abstract][Full Text] [Related]
7. Automated treatment planning engine for prostate seed implant brachytherapy.
Yu Y; Zhang JB; Brasacchio RA; Okunieff PG; Rubens DJ; Strang JG; Soni A; Messing EM
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):647-52. PubMed ID: 10078652
[TBL] [Abstract][Full Text] [Related]
8. Inverse automated treatment planning with and without individual optimization in interstitial permanent prostate brachytherapy with high- and low-activity 125I.
Pinkawa M; Maurer U; Mulhern A; Gagel B; Block T; Borchers H; Grieger J; Henkel T; Eble M
Strahlenther Onkol; 2003 Jun; 179(6):417-22. PubMed ID: 12789469
[TBL] [Abstract][Full Text] [Related]
9. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of interactive planned and dynamic dose calculated prostate seed brachytherapy.
Meijer GJ; van den Berg HA; Hurkmans CW; Stijns PE; Weterings JH
Radiother Oncol; 2006 Sep; 80(3):378-84. PubMed ID: 16930753
[TBL] [Abstract][Full Text] [Related]
11. Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants.
Horwitz EM; Mitra RK; Uzzo RG; Das IJ; Pinover WH; Hanlon AL; McNeeley SW; Hanks GE
Radiother Oncol; 2003 Feb; 66(2):173-9. PubMed ID: 12648789
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative dynamic dose optimization in permanent prostate implants.
Lee EK; Zaider M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):854-61. PubMed ID: 12788195
[TBL] [Abstract][Full Text] [Related]
13. Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.
Todor DA; Barani IJ; Lin PS; Anscher MS
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):297-304. PubMed ID: 21536392
[TBL] [Abstract][Full Text] [Related]
14. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
[TBL] [Abstract][Full Text] [Related]
15. Is intraoperative nomogram-based overplanning of prostate implants necessary?
D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric and volumetric criteria for selecting a source activity and a source type ((125)I or (103)Pd) in the presence of irregular seed placement in permanent prostate implants.
Wuu CS; Ennis RD; Schiff PB; Lee EK; Zaider M
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):815-20. PubMed ID: 10837969
[TBL] [Abstract][Full Text] [Related]
17. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique.
Zelefsky MJ; Yamada Y; Cohen G; Venkatraman ES; Fung AY; Furhang E; Silvern D; Zaider M
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):601-8. PubMed ID: 10974481
[TBL] [Abstract][Full Text] [Related]
18. On the determination of an effective planning volume for permanent prostate implants.
Lee EK; Zaider M
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1197-206. PubMed ID: 11240263
[TBL] [Abstract][Full Text] [Related]
19. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
[TBL] [Abstract][Full Text] [Related]
20. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
